The U.S. Food and Drug Administration’s (FDA) has released information regarding entry line refusals for first month of 2017. In total, 8 of the 145 (5.5%) entry line refusals in January were of shrimp for reasons related to banned antibiotics.
The total number of entry line rejections in January was the highest in a month since August of last year. The eight shrimp entry lines refused by the FDA for banned antibiotics in January were from Thailand, Vietnam, and China and were reported by three different FDA districts:
- Narong Seafood Co., Ltd. (Thailand), a company that has been listed on Import Alert 16-129 for nitrofurans in its shrimp since June 13, 2016, had a total of five entry lines refused for shrimp products contaminated with nitrofurans and veterinary drug residues in the New England District – three of “shrimp and prawns,” one of “shrimp chow mein dinners, mixed fishery/seafood products,” and one of “stuffed pasta with shrimp (N.E.C.), mixed fishery/seafood products;
To read the rest of the story, please go to: Southern Shrimp Alliance
